Single dose, open label, uncontrolled, safety trial

Project: Research project

Project Details

Description

Single dose, open label, uncontrolled, safety trial of intravenous administration of idarucizumab to paediatric patients enrolled from ongoing phase IIb/III clinical trials with dabigatran etexilate for the
StatusFinished
Effective start/end date7/1/1612/31/19

Funding

  • Boehringer-Ingelheim Pharmaceuticals

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.